Mucopolysaccharidosis Type 3B (MPS IIIB, Sanfilippo Syndrome B) Latest Advances
Find the Latest Research About Mucopolysaccharidosis Type 3B (MPS IIIB, Sanfilippo Syndrome B)
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 192 publications
Personalized Drug Repurposing Screen Identifies Patient-Specific Therapeutic Candidates for Mucopolysaccharidosis Type IIIB.
Journal: Journal of personalized medicine
Published: May 12, 2026
Author Correction: TFEB, FOXO3 and TLR4 in resveratrol-induced autophagy in a mucopolysaccharidosis IIIB mouse model.
Journal: Experimental & molecular medicine
Published: March 18, 2026
Molecular Modeling of N-Acetylglucosamine Binding to the I154R Mutant of NAGLU: Pathogenic Insights into Sanfilippo Syndrome Type B.
Journal: International journal of molecular sciences
Published: March 16, 2026
Evaluation of GlcNAc-Configured Glycomimetics as Pharmacological Chaperones of NAGLU for the Treatment of Mucopolysaccharidosis IIIB.
Journal: Biomolecules
Published: December 20, 2025
Variant profile of Brazilian patients with Sanfilippo syndrome type B.
Journal: Genetics and molecular biology
Published: August 15, 2025
Comprehensive Characterization of a Cluster of Mucopolysaccharidosis IIIB in Ecuador.
Journal: Diagnostics (Basel, Switzerland)
Published: August 06, 2025
Clinical, biochemical, and molecular characterization of a cohort of Egyptian patients with Sanfilippo B syndrome (MPS IIIB): Bayesian Gaussian mixture model.
Journal: Molecular biology reports
Published: July 22, 2025
Heparan sulfate binding protein treatment ameliorates neuropathology and behavioral abnormalities in mucopolysaccharidosis IIIB mice.
Journal: Cell death discovery
Published: May 12, 2025
A Rare Compound Heterozygous NAGLU Gene Mutation in Two Siblings with Mucopolysaccharidosis type Iiib.
Journal: Iranian journal of pathology
Published: May 05, 2025
Whole-Exome sequencing and systems biology approaches revealed pathogenicity of compound heterozygote variants of NAGLU gene manifesting developmental regression, brain atrophy, intellectual disability, and ADHD.
Journal: Molecular biology reports
Published: April 07, 2025
TFEB, FOXO3 and TLR4 in resveratrol-induced autophagy in a mucopolysaccharidosis IIIB mouse model.
Journal: Experimental & molecular medicine
Published: February 14, 2025
Shared Gene Expression Dysregulation Across Subtypes of Sanfilippo and Morquio Diseases: The Role of PFN1 in Regulating Glycosaminoglycan Levels.
Journal: Frontiers in bioscience (Landmark edition)
Published: September 30, 2024
Last Updated: 09/26/2026